Pfizer Inc. and two of its subsidiaries have agreed to pay $345 million under a proposed settlement to resolve litigation over EpiPen price hikes
Related posts
-
Transit’s fiscal cliff gets steeper as leaders warn of ‘death spiral’
Metra, Pace and the CTA delivered their 2025 budgets to the RTA Friday but the big... -
Student-designed nutcrackers on display this weekend in Rosemont
More than two dozen human-sized nutcrackers sculptures custom painted by high school students went on display... -
All on board: Bensenville rallies behind food pantry after holiday train schedule change
Bensenville rallied to collect money and items for a community food pantry after learning a holiday...